Desq Long
Sign in

Company

Ultragenyx Pharmaceutical Inc.

RARE · CIK 0001515673

SEC FORM 4
$107,897.82

Ultragenyx Pharmaceutical Inc. (RARE)

Sale of 7,066 shares at $15.27 per share.

Reporting Person Horn Howard · Officer Title Chief Financial Officer · Transaction Code S

Traded Oct 15, 2026 · Disclosed Oct 19, 2026

Source: SEC Form 4 · 0001193125-26-425032 · filed 2026-10-19 · View filing →

SEC FORM 4
$17,410.31

Ultragenyx Pharmaceutical Inc. (RARE)

Sale of 1,283 shares at $13.57 per share.

Reporting Person Huizenga Theodore Alan · Officer Title SVP, Chief Accounting Officer · Transaction Code S

Traded Sep 15, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001193125-26-392233 · filed 2026-09-15 · View filing →

SEC FORM 4
$2,252.39

Ultragenyx Pharmaceutical Inc. (RARE)

Sale of 161 shares at $13.99 per share.

Reporting Person Huizenga Theodore Alan · Officer Title SVP, Chief Accounting Officer · Transaction Code S

Traded Sep 3, 2026 · Disclosed Sep 8, 2026

Source: SEC Form 4 · 0001193125-26-384878 · filed 2026-09-08 · View filing →